PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 25 filers reported holding PROQR THRAPEUTICS N V in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,042,000 | -81.8% | 212,698 | -75.3% | 0.01% | -80.8% |
Q3 2016 | $5,739,000 | -3.9% | 860,464 | -30.3% | 0.05% | -17.5% |
Q2 2016 | $5,973,000 | -9.3% | 1,234,095 | -8.6% | 0.06% | -8.7% |
Q1 2016 | $6,587,000 | -23.2% | 1,349,719 | +36.6% | 0.07% | -2.8% |
Q4 2015 | $8,578,000 | -40.4% | 988,299 | 0.0% | 0.07% | -46.6% |
Q3 2015 | $14,400,000 | -12.6% | 988,299 | 0.0% | 0.13% | -8.3% |
Q2 2015 | $16,475,000 | +88.2% | 988,299 | +147.1% | 0.14% | +98.6% |
Q1 2015 | $8,752,000 | +1.0% | 400,000 | 0.0% | 0.07% | -17.0% |
Q4 2014 | $8,668,000 | +26.1% | 400,000 | 0.0% | 0.09% | +1.1% |
Q3 2014 | $6,876,000 | – | 400,000 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |